Harborside Inc. (“Harborside” or the “Company”) (CSE: HBOR) (OTCQX: HBORF) a California-focused, vertically integrated cannabis enterprise, today announced today that it has granted options (each, an “Option”) to purchase an aggregate of 684,985 subordinate voting shares of the Company (“SVS”) to certain employees of the Company. Each Option is exercisable into one SVS in the capital of the Company at an exercise price of $2.21 per SVS. The Options will expire five years from the date of grant and are subject to vesting conditions. All Options were granted in accordance with Harborside’s equity incentive plan adopted by the board of directors of the Company on June 30, 2020 and approved by shareholders on November 24, 2020 (the “Plan”). A copy of the Plan is available under the Company’s SEDAR profile at www.sedar.com.
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the Canadian Securities Exchange (“CSE”) trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Harborside Inc.